Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chawla

Showing results (61-70 of 171) with videos related to

Pageof 18
Sort By:
Journal of Surgical Oncology|January 1, 1989
Advanced basal cell carcinoma and successful treatment with chemotherapyS P Chawla, R S Benjamin, A G Ayala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 15, 2009
Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancerSant P Chawla, Victoria S Chua, Lita Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules S S Legha, N E Papadopoulos, C Plager, et al.
Cancer Treatment Reports|March 1, 1986
Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomasJ A Ajani, I Dimery, S P Chawla, et al.
Journal of Biomedical Materials Research. Part A|November 23, 2013
Comparative analysis of in vitro oxidative degradation of poly(carbonate urethanes) for biostability screeningDavid K Dempsey, Christopher Carranza, Chander P Chawla, et al.
American Journal of Clinical Oncology|February 1, 1989
A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancerG N Hortobagyi, H Y Yap, S W Kau, et al.
Investigational New Drugs|November 1, 2013
A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of TumorsRobin L Jones, Stefano Ferrari, Jean Yves Blay, et al.
Oncology Reports|September 3, 2010
Pathotropic targeting advances clinical oncology: tumor-targeted localization of therapeutic gene deliveryFrederick L Hall, John P Levy, Rebecca A Reed, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2009
Phase I/II and phase II studies of targeted gene delivery in vivo: intravenous Rexin-G for chemotherapy-resistant sarcoma and osteosarcomaSant P Chawla, Victoria S Chua, Lita Fernandez, et al.
Texas Heart Institute Journal|August 6, 2000
Angiogenesis in a patient with ischemic limb induced by intramuscular injection of vascular endothelial growth factor and fibrin platformN Kipshidze, V Chekanov, P Chawla, et al.
Pageof 18

Showing results (61-70 of 171) with videos related to

Sort By:
Pageof 18
Journal of Surgical Oncology|January 1, 1989
Advanced basal cell carcinoma and successful treatment with chemotherapyS P Chawla, R S Benjamin, A G Ayala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 15, 2009
Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancerSant P Chawla, Victoria S Chua, Lita Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules S S Legha, N E Papadopoulos, C Plager, et al.
Cancer Treatment Reports|March 1, 1986
Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomasJ A Ajani, I Dimery, S P Chawla, et al.
Journal of Biomedical Materials Research. Part A|November 23, 2013
Comparative analysis of in vitro oxidative degradation of poly(carbonate urethanes) for biostability screeningDavid K Dempsey, Christopher Carranza, Chander P Chawla, et al.
American Journal of Clinical Oncology|February 1, 1989
A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancerG N Hortobagyi, H Y Yap, S W Kau, et al.
Investigational New Drugs|November 1, 2013
A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of TumorsRobin L Jones, Stefano Ferrari, Jean Yves Blay, et al.
Oncology Reports|September 3, 2010
Pathotropic targeting advances clinical oncology: tumor-targeted localization of therapeutic gene deliveryFrederick L Hall, John P Levy, Rebecca A Reed, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2009
Phase I/II and phase II studies of targeted gene delivery in vivo: intravenous Rexin-G for chemotherapy-resistant sarcoma and osteosarcomaSant P Chawla, Victoria S Chua, Lita Fernandez, et al.
Texas Heart Institute Journal|August 6, 2000
Angiogenesis in a patient with ischemic limb induced by intramuscular injection of vascular endothelial growth factor and fibrin platformN Kipshidze, V Chekanov, P Chawla, et al.
Pageof 18